newsfilter
← Latest News
GlobeNewswire·

NightHawk Biosciences to Present at the 4th Annual Treg Directed Therapies Summit on PTX-35

DURHAM, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE:NHWK), a fully integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Matthew Seavey, Ph.D., MBA